Effect of Statin Use on Liver Enzymes and Lipid Profile in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with the prevalence of approximately 30%.1 The prevalence goes up among specific high-risk populations: 30-50% in patients with type 2 diabetes, and 80-90% in patients with obesity.2,3
Source: Journal of Clinical Lipidology - Category: Lipidology Authors: Anh Ho, Takako Kiener, Quynh-Nhu Nguyen, Quang A. Le Tags: Original Research Source Type: research